Abstract
Background/Aims
Endoscopic submucosal dissection (ESD) is an effective procedure for en-bloc curative resection of the colorectal tumor. As it requires high technical skills and experience in therapeutic endoscopy, it is important to understand learning curve of ESD technique. The aim of this study was to retrospectively describe the clinical results of ESD and to evaluate learning curve for the ESD of colorectal tumors.
Methods
A total of 90 patients with 90 colorectal neoplasms, who had undergone ESD at a tertiary referral hospital from July 2009 to December 2012, were enrolled. The ESD was performed by a single endoscopist. All ESD cases were divided into three periods: first, cases 1–30; second, cases 31–60; and third, cases 61–90.
Results
The en-bloc resection rates in third period (100%) was significantly higher than that of the first (93.3%) and second period (80%) (p=0.025). The perforation rate in third period (0%) also significantly decreased compared with that of the first (13.3%) and second period (20%) (p=0.032). To calibrate the difference of tumor size among periods, proficiency was calculated, as the procedure time per specimen area (min/cm2). The proficiency in third period (4.3) was significantly shorter than that of the first (16.8) and second period (10.2) (p=0.004).
References
1. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116:544–573.

2. Byeon JS, Yang DH, Kim KJ, et al. Endoscopic submucosal dissection with or without snaring for colorectal neoplasms. Gastrointest Endosc. 2011; 74:1075–1083.

3. Puli SR, Kakugawa Y, Gotoda T, Antillon D, Saito Y, Antillon MR. Meta-analysis and systematic review of colorectal endoscopic mucosal resection. World J Gastroenterol. 2009; 15:4273–4277.

4. Hotta K, Fujii T, Saito Y, Matsuda T. Local recurrence after endoscopic resection of colorectal tumors. Int J Colorectal Dis. 2009; 24:225–230.

5. Tanaka S, Haruma K, Oka S, et al. Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc. 2001; 54:62–66.

6. Thorlacius H, Uedo N, Toth E. Implementation of endoscopic submucosal dissection for early colorectal neoplasms in Sweden. Gastroenterol Res Pract. 2013; 2013:758202.

7. Hotta K, Saito Y, Matsuda T, Shinohara T, Oyama T. Local recurrence and surveillance after endoscopic resection of large colorectal tumors. Dig Endosc. 2010; 22(Suppl 1):S63–S68.

8. Yoshida N, Naito Y, Sakai K, et al. Outcome of endoscopic submucosal dissection for colorectal tumors in elderly people. Int J Colorectal Dis. 2010; 25:455–461.

9. Zhou PH, Yao LQ, Qin XY. Endoscopic submucosal dissection for colorectal epithelial neoplasm. Surg Endosc. 2009; 23:1546–1551.

10. Saito Y, Sakamoto T, Fukunaga S, Nakajima T, Kiriyama S, Matsuda T. Endoscopic submucosal dissection (ESD) for colorectal tumors. Dig Endosc. 2009; 21(Suppl 1):S7–S12.

11. Saito Y, Uraoka T, Matsuda T, et al. Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest Endosc. 2007; 66:966–973.

12. Tanaka S, Oka S, Kaneko I, et al. Endoscopic submucosal dissection for colorectal neoplasia: possibility of standardization. Gastrointest Endosc. 2007; 66:100–107.

13. Jamg MY, Cho JW, Oh WG, et al. A case of pneumorrhachis and pneumoscrotum following colon endoscopic submucosal dissection. Intest Res. 2013; 11:208–212.

14. Saito Y, Fukuzawa M, Matsuda T, et al. Clinical outcome of endoscopic submucosal dissection versus endoscopic mucosal re-section of large colorectal tumors as determined by curative resection. Surg Endosc. 2010; 24:343–352.

15. Uraoka T, Kawahara Y, Kato J, Saito Y, Yamamoto K. Endoscopic submucosal dissection in the colorectum: present status and future prospects. Dig Endosc. 2009; 21(Suppl 1):S13–S16.

16. Saito Y, Otake Y, Sakamoto T, et al. Indications for and technical aspects of colorectal endoscopic submucosal dissection. Gut Liver. 2013; 7:263–269.

17. Matsuda T, Fujii T, Saito Y, et al. Efficacy of the invasive/non-in-vasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol. 2008; 103:2700–2706.

18. Ohata K, Ito T, Chiba H, Tsuji Y, Matsuhashi N. Effective training system in colorectal endoscopic submucosal dissection. Dig Endosc. 2012; 24(Suppl 1):84–89.

19. Hotta K, Oyama T, Shinohara T, et al. Learning curve for endoscopic submucosal dissection of large colorectal tumors. Dig Endosc. 2010; 22:302–306.

20. Nishiyama H, Isomoto H, Yamaguchi N, et al. Endoscopic submucosal dissection for colorectal epithelial neoplasms. Dis Colon Rectum. 2010; 53:161–168.

21. Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S. New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy. 2001; 33:221–226.

22. Sakamoto T, Saito Y, Fukunaga S, Nakajima T, Matsuda T. Learning curve associated with colorectal endoscopic submucosal dissection for endoscopists experienced in gastric endoscopic submucosal dissection. Dis Colon Rectum. 2011; 54:1307–1312.

23. Tanaka S, Oka S, Chayama K. Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection. J Gastroenterol. 2008; 43:641–651.

24. Saito Y, Uraoka T, Matsuda T, et al. A pilot study to assess the safe-ty and efficacy of carbon dioxide insufflation during colorectal endoscopic submucosal dissection with the patient under con-scious sedation. Gastrointest Endosc. 2007; 65:537–542.

25. Fujishiro M, Yahagi N, Kakushima N, et al. Outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms in 200 consecutive cases. Clin Gastroenterol Hepatol. 2007; 5:678–683. quiz 645.

26. Isomoto H, Nishiyama H, Yamaguchi N, et al. Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy. 2009; 41:679–683.

27. Niimi K, Fujishiro M, Kodashima S, et al. Long-term outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy. 2010; 42:723–729.

28. Tamegai Y, Saito Y, Masaki N, et al. Endoscopic submucosal dissection: a safe technique for colorectal tumors. Endoscopy. 2007; 39:418–422.

29. Yoshida N, Wakabayashi N, Kanemasa K, et al. Endoscopic submucosal dissection for colorectal tumors: technical difficulties and rate of perforation. Endoscopy. 2009; 41:758–761.

30. Huang C, Huang RX, Xiang P, Qiu ZJ. Current research status of endoscopic submucosal dissection for colorectal neoplasms. Clin Invest Med. 2012; 35:E158–E164.

31. Yoshida N, Yagi N, Naito Y, Yoshikawa T. Safe procedure in endoscopic submucosal dissection for colorectal tumors focused on preventing complications. World J Gastroenterol. 2010; 16:1688–1695.

32. Kawabe T, Ichinose M, Omata M. Successful nonsurgical management of perforation complicating endoscopic submucosal dissection of gastrointestinal epithelial neoplasms. Endoscopy. 2006; 38:1001–1006.

33. Toyanaga T, Man-I M, Ivanov D, et al. The results and limitations of endoscopic submucosal dissection for colorectal tumors. Acta Chir Iugosl. 2008; 55:17–23.

34. Park HW, Byeon JS, Park YS, et al. Endoscopic submucosal dissection for treatment of rectal carcinoid tumors. Gastrointest Endosc. 2010; 72:143–149.

35. Lee DS, Jeon SW, Park SY, et al. The feasibility of endoscopic submucosal dissection for rectal carcinoid tumors: comparison with endoscopic mucosal resection. Endoscopy. 2010; 42:647–651.

36. Moon SH, Hwang JH, Sohn DK, et al. Endoscopic submucosal dissection for rectal neuroendocrine (carcinoid) tumors. J Laparoendosc Adv Surg Tech A. 2011; 21:695–699.

37. Yamaguchi N, Isomoto H, Nishiyama H, et al. Endoscopic submucosal dissection for rectal carcinoid tumors. Surg Endosc. 2010; 24:504–508.

38. Zhou PH, Yao LQ, Xu MD, et al. Endoscopic submucosal dissection for rectal carcinoid tumors. Zhonghua Wei Chang Wai Ke Za Zhi. 2007; 10:319–322.
Fig. 1.
Learning curve of procedure time per specimen area (min/cm2). The values represent mean proficiency in each period.
Table 1.
Patient Demographics and Endoscopic Characteristics of the Lesions by Treatment Period
| Characteristic | 1st period | 2nd period | 3rd period | p-value |
|---|---|---|---|---|
| Age (yr) | 59.1 (36–79) | 58.9 (41–76) | 62.2 (35–81) | 0.538 |
| Gender (n, male:female) | 14:16 | 18:12 | 21:9 | 0.183 |
| Comobidity | ||||
| Hypertension | 12 (40.0) | 12 (40.0) | 9 (30.0) | 0.650 |
| Type 2 DM | 8 (26.7) | 3 (10.0) | 5 (16.7) | 0.236 |
| CLD | 2 (6.7) | 0 (0.0) | 1 (3.3) | 0.770 |
| CVD | 0 (0.0) | 0 (0.0) | 2 (6.7) | 0.326 |
| CRD | 2 (6.7) | 1 (3.3) | 0 (0.0) | 0.770 |
| Others a | 2 (6.7) | 3 (10.0) | 2 (6.7) | 1.000 |
| Location of tumors b | 0.426 | |||
| Right colon | 7 (23.3) | 7 (23.3) | 10 (33.3) | |
| Left colon | 3 (10.0) | 6 (20.0) | 7 (23.3) | |
| Rectum | 20 (66.7) | 17 (56.7) | 13 (43.3) | |
| Endoscopic diagnosis | 0.314 | |||
| LST-G | 11 (36.7) | 15 (50.0) | 14 (46.7) | |
| LST-NG | 3 (10.0) | 4 (13.3) | 8 (26.7) | |
| Polypoid | 6 (20.0) | 3 (10.0) | 4 (13.3) | |
| Carcinoid | 10 (33.3) | 8 (26.7) | 4 (13.3) | |
| Tumor size, long axis (mm) | 20.9 (9–40) | 24.9 (10–55) | 23.8 (9–45) | 0.359 |
| Duration per ESD (day) | 16.5 | 13.1 | 12.1 |
Chronologically all cases were divided according to three periods: first period, cases 1–30; second period, cases 31–60; third period, cases 61–90.
Type 2 DM, type 2 diabetes mellitus; CLD, chronic liver disease; CVD, cardiovascular disease; CRD, chronic renal disease; LST-G, laterally spreading tumor-granular type; LST-NG, laterally spreading tumor-nongranular type; ESD, endoscopic submucosal dissection.
Table 2.
Clinicopathological Outcomes by Treatment Period
| 1st period | 2nd period | 3rd period | p-value | |
|---|---|---|---|---|
| Pathology | 0.217 | |||
| Adenoma | 11 (36.7) | 13 (43.3) | 14 (46.7) | |
| Adenocarcinoma | 8 (26.7) | 9 (30.0) | 13 (43.3) | |
| Intramucosal cancer | 6 (20.0) | 6 (20.0) | 11 (36.7) | |
| Submucosal cancer | ||||
| Shallow (<1,000 μm) | 1 (3.3) | 2 (6.7) | 1 (3.3) | |
| Deep (≥1,000 μm) | 1 (3.3) | 1 (3.3) | 1 (3.3) | |
| Carcinoid tumor | 9 (30.0) | 8 (26.7) | 2 (6.7) | |
| Others a | 2 (6.7) | 0 (0.0) | 1 (3.3) | |
| Procedure time, min | 39 (10–100) | 31.5 (8–133) | 15 (5–100) | 0.034 |
| En-bloc resection | 28 (93.3) | 24 (80.0) | 30 (100.0) | 0.025 |
| R0 resection b | 27 (90.0) | 21 (70.0) | 27 (90.0) | 0.056 |
| Perforation | 4 (13.3) | 6 (20.0) | 0 (0.0) | 0.032 |
Table 3.
Clinicopathological Outcomes by Treatment Period in Colorectal Epithelial Tumors
| 1st period | 2nd period | 3rd period | p-value | |
|---|---|---|---|---|
| Tumor size, long axis (mm), mean (range) | 25.6 (20–40) | 30.2 (21–55) | 26.9 (20–47) | 0.199 |
| Procedure time (min), median (range) | 51.6 (15–100) | 47.4 (8–133) | 27.7 (5–100) | 0.023 |
| En-bloc resection, n (%) | 18 (90.0) | 16 (72.7) | 26 (100.0) | 0.008 |
| R0 resection a, n (%) | 17 (85.0) | 14 (63.6) | 23 (88.5) | 0.124 |
| Perforation, n (%) | 4 (20.0) | 6 (27.3) | 0 (0.0) | 0.008 |
| Proficiency (min/cm2), mean only | 12.7 | 7.4 | 4.2 | 0.02 |



PDF
ePub
Citation
Print


XML Download